Search results
Results From The WOW.Com Content Network
Ranbaxy's Malvinder Singh remained as CEO after the transaction. [11] The addition of Ranbaxy Laboratories extended Daiichi-Sankyo's operations, with the combined company worth about US$30 billion. [12] In 2009, it was reported that former Novartis Senior Vice-President Yugal Sikri would lead the Indian operations of Ranbaxy Laboratories. [13] [14]
In 2006, Advent had sold 96.7% of the company to Ranbaxy. Terapia S.A. therefore went through a brand name change, and so it became Terapia Ranbaxy. Two years later, the Japanese pharmaceutical giant Daiichi Sankyo had purchased 1/5 of the company, and so Terapia Ranbaxy became part of the giant.
From Wikipedia, the free encyclopedia. Redirect page
UConn had a last look at the basket following a timeout with 5.9 seconds remaining. But Hassan Diarra's go-ahead 3-point attempt clanged off the rim just before the final buzzer sounded.
An Ohio couple who tortured their five adopted sons in “dungeon”-like conditions and deprived them of food and water, among other abuses, has been sentenced after taking a plea deal.
The bird flu outbreak has taken concerning turns, with more than 60 human cases confirmed. Experts outlined four signs that the virus is going in the wrong direction.
Ranbaxy was way more than simply "laden with controversy" as currently stated in the introduction, and the Controversies section currently does not make it clear that the company's "whose business model was completely dependent on falsifying data in their drug applications to the FDA" (in the words of Katherine Eban's interviewer).
“The first surgery had a 60% chance of giving him seizure freedom, and the second surgery had a 50% chance of giving seizure freedom,” Andalusia says. “It did not give him seizure freedom.”